Alpha Teknova Inc Total Liabilities
Alpha Teknova Inc total liabilities. Based on the latest financial reports, Alpha Teknova Inc (TKNO) has total liabilities worth $33.73 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Alpha Teknova Inc to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Alpha Teknova Inc (2019–2025)
Total liabilities of Alpha Teknova Inc from 2019 to 2025. This chart illustrates how Alpha Teknova Inc's total liabilities have evolved over time, based on quarterly financial data.
Alpha Teknova Inc Competitors by Total Liabilities
The table below lists competitors of Alpha Teknova Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$258.88 Million |
|
Sanstar Ltd
NSE:SANSTAR
|
India | Rs1.09 Billion |
|
Imexpharm Corp
VN:IMP
|
Vietnam | ₫605.60 Billion |
|
Ucore Rare Metals Inc
V:UCU
|
Canada | CA$12.42 Million |
|
Kuo Yang Construction Co Ltd
TW:2505
|
Taiwan | NT$12.76 Billion |
|
Zanlakol Ltd
TA:ZNKL
|
Israel | ILA234.22 Million |
|
North-Star International Co Ltd
TWO:8927
|
Taiwan | NT$24.47 Billion |
|
Mulpha International Bhd
KLSE:3905
|
Malaysia | RM2.40 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Alpha Teknova Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Alpha Teknova Inc total assets.
Liquidity & Leverage Metrics
Alpha Teknova Inc Total Liabilities Ratios Explained
Alpha Teknova Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alpha Teknova Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alpha Teknova Inc (2019–2025)
The table below shows the annual total liabilities of Alpha Teknova Inc from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $34.81 Million | -4.31% |
| 2024-12-31 | $36.38 Million | -5.64% |
| 2023-12-31 | $38.55 Million | -26.40% |
| 2022-12-31 | $52.38 Million | +124.71% |
| 2021-12-31 | $23.31 Million | +121.85% |
| 2020-12-31 | $10.51 Million | -76.96% |
| 2019-12-31 | $45.60 Million | -- |
About Alpha Teknova Inc
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sam… Read more